USPTO serial 87736581
ASCLEPIUS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SHANAHAN, PATRICK
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ASCLEPIUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Deborah J Peckham
DEBORAH J PECKHAM BURNS & LEVINSON LLP125 High StreetBOSTON, MA 02110UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for diagnostic assessment and therapeutic targeting of RNA, namely, for ribosomal RNA, miRNA, siRNA, exoRNA, RNA fragments, and viral RNA for medical and scientific research purposes; pharmaceutical preparations for the treatment and prevention of a wide variety of diseases and disorders, namely, genetic diseases and disorders, proliferative diseases and disorders, neoplasias, tumourous diseases and disorders, and cancer; pharmaceutical preparations, namely, RNA-targeting therapeutics for the treatment and prevention a wide variety of diseases and disorders namely, genetic diseases and disorders, proliferative diseases and disorders, neoplasias, tumourous diseases and disorders, and cancer; pharmaceutical products for the prevention and treatment of a wide variety of diseases and disorders, namely, genetic diseases and disorders, proliferative diseases and disorders, neoplasias, tumourous diseases and disorders, and cancer; biologic preparations and compounds for the treatment and prevention of genetic diseases and disorders, proliferative diseases and disorders, neoplasias, tumourous diseases and disorders, and cancer | ACTIVE | — |
| 042 | Pharmaceutical, medical and scientific research and development; pharmaceutical, medical and scientific research consulting; pharmaceutical, medical and scientific research; providing pharmaceutical, medical and scientific research information | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by The RNA Medicines Company Inc.
- Other trademarks owned by The RNA Medicines Company Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ASCLEPIUS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 2, 2020 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 2, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 31, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 29, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 29, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 29, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 11, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 29, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 4, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 4, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 14, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 27, 2018 | ALIE | ASSIGNED TO LIE | — |
| Oct 15, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 24, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 24, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 24, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 10, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 9, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 12, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2018 | NWAP | NEW APPLICATION ENTERED | — |